MAPT and tauopathy: Using biochemical purification and quantitative MS, we showed that 4R isoform-specific MTBR-tau275 and MTBR-tau282 that are normalized to t-tau decrease in the CSF soluble tau as they increase in brain insoluble tau in primary tauopathies, especially CBD and FTLD-MAPT P301L.